Lauren D’Angelo, MBA
About
Lauren D’Angelo, MBA is an experienced executive with significant commercial experience, product launch, and cross-functional managerial leadership with board level accountability. With over 25 years of experience in the biotech/pharmaceutical industry, Ms. D’Angelo has been integral in the launch and resulting commercial success of products in CNS, Neurology, Oncology, Urology, Cardiovascular, Diabetes, Respiratory, GI, Pain, and Rare Disease.
Ms. D’Angelo has extensive experience ranging from large global companies (AstraZeneca, Genentech), mid-size companies (Avanir Pharmaceuticals and Medivation), and emerging pre-commercial, turned commercial stage companies (Urovant and Alpha Cognition). The expanse of Ms. D’Angelo’s experience includes joining pre-commercial companies as the first commercial hire and Employee #2, Employee #3, at two companies, developing and leading 20+ launch plans resulting in 8 blockbuster brands, and building and transforming small pharma/biotech companies, with financing and capital markets success. Ms. D’Angelo’s past 3 companies achieved M&A transactions exceeding $17B.
Ms. D’Angelo currently serves as Chief Operating Officer and Chief Commercial Officer at Alpha Cognition, a pharma start-up company innovating in Alzheimer’s disease (AD) and neurodegenerative diseases. Under her leadership as COO, the organization not only secured FDA approval for ZUNVEYL, a treatment indicated for Alzheimer's disease—and only the second oral therapy approved in AD in over a decade—but did so with a lean team of just four full-time employees. This significant achievement highlights her ability to navigate complex regulatory landscapes and deliver impactful solutions in a challenging therapeutic area. Her leadership has not only improved operational efficiency but has also positioned the organization for future growth and success.
Ms. D’Angelo has a mind for business, a heart for people, and a passion for delivering results. What makes Lauren stand out in the healthcare sector is her unique blend of compassion, intelligence, and hands-on leadership. She not only brings exceptional strategic and analytical skills to the table but also leads with a deep sense of empathy and kindness. This combination is rare and invaluable, particularly in the healthcare industry, where understanding patient needs and fostering a supportive work environment are crucial.
Ms. D’Angelo has received numerous industry rewards and recognition including 2023 PharmaVoice 100 Top Industry Leader, 2022 Medical Marketing & Media, Women of Distinction, 2021 PM360 Trailblazer, Product Launch of the Year, 2020 Pharmaceutical Executive, Emerging Pharma Leader, and 2017 MM&M Women to Watch.
Ms. D’Angelo has extensive experience ranging from large global companies (AstraZeneca, Genentech), mid-size companies (Avanir Pharmaceuticals and Medivation), and emerging pre-commercial, turned commercial stage companies (Urovant and Alpha Cognition). The expanse of Ms. D’Angelo’s experience includes joining pre-commercial companies as the first commercial hire and Employee #2, Employee #3, at two companies, developing and leading 20+ launch plans resulting in 8 blockbuster brands, and building and transforming small pharma/biotech companies, with financing and capital markets success. Ms. D’Angelo’s past 3 companies achieved M&A transactions exceeding $17B.
Ms. D’Angelo currently serves as Chief Operating Officer and Chief Commercial Officer at Alpha Cognition, a pharma start-up company innovating in Alzheimer’s disease (AD) and neurodegenerative diseases. Under her leadership as COO, the organization not only secured FDA approval for ZUNVEYL, a treatment indicated for Alzheimer's disease—and only the second oral therapy approved in AD in over a decade—but did so with a lean team of just four full-time employees. This significant achievement highlights her ability to navigate complex regulatory landscapes and deliver impactful solutions in a challenging therapeutic area. Her leadership has not only improved operational efficiency but has also positioned the organization for future growth and success.
Ms. D’Angelo has a mind for business, a heart for people, and a passion for delivering results. What makes Lauren stand out in the healthcare sector is her unique blend of compassion, intelligence, and hands-on leadership. She not only brings exceptional strategic and analytical skills to the table but also leads with a deep sense of empathy and kindness. This combination is rare and invaluable, particularly in the healthcare industry, where understanding patient needs and fostering a supportive work environment are crucial.
Ms. D’Angelo has received numerous industry rewards and recognition including 2023 PharmaVoice 100 Top Industry Leader, 2022 Medical Marketing & Media, Women of Distinction, 2021 PM360 Trailblazer, Product Launch of the Year, 2020 Pharmaceutical Executive, Emerging Pharma Leader, and 2017 MM&M Women to Watch.
